Bullboard Post History

RE: RE: Breakout

We are getting close, but in the past, a .20-.30 move on this type of news is...

Breakout

I am surprised that investors have not pulled some of their ask orders. I was...

Market orders

Overall, these small market sell/buy orders probably mean nothing, but I feel...

Finally, Diagnocure's name in the news

New studies show DiagnoCure's PCA3 prostate cancer marker can help guide...

3/8 ASCO story

PROGENSA(R) PCA3 Assay Can Help Guide Repeat Prostate Biopsy Decisions, Data...

additional story 3/7

PCA3 Urine Test Predicts Prostate Cancer Biopsy Results: Presented at ASCO...

RE: T2-ERG was a convenient excuse for delaying

I agree with you 100%, PCA3 should have been FDA approved years ago to take...

ASCO

ASCO GU: New Test Gets Positive Results for Prostate CA ...

RE: News/trials

I just noticed this on TheStreet.com On a related note, positive clinical...

News/trials

I have friends at ASCO this weekend and I am looking forward to what they...

RE: ENHANCED CREDIBILITY/EXPOSURE.

Now is the time to get the share price moving. Without a doubt this is...

RE: additional old research comments (2005)

Even under our conservative initial assumptions, DiagnoCure has thepotential...

additional old research comments (2005)

Investment RewardsDiagnoCure’s PCA3 marker may offer unique advantages over...

old research comment on GSK study

The GSK CollaborationWe believe this collaboration is a validation of PCA3...

GPRO up early

GPRO is up early on anticipation of positive trial results this week. ...

RE: Phase III trial results Wed (2,000 men)

2010 Genitourinary Cancers Symposium Press Program Announced ...

Phase III trial results Wed (2,000 men)

GCC webinar

This is around 15 min long. http://www.diagnocurelabs.com/GCCWebinar1/ (I...

additional pca3 news

The Prostate Cancer gene 3 assay: indications for use in clinical...

42 slide presentation

Monday, 22 February 2010 VAIL, CO...